Filing Details
- Accession Number:
- 0001104659-18-019018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-03-20 17:43:31
- Reporting Period:
- 2018-03-16
- Accepted Time:
- 2018-03-20 17:43:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640266 | Voyager Therapeutics Inc. | VYGR | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422304 | Jane Henderson | C/O Voyager Therapeutics 75 Sidney Street Cambridge MA 02139 | Cfo & Svp, Corp. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-03-16 | 15,416 | $11.97 | 15,416 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-16 | 15,416 | $22.15 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-03-19 | 1,900 | $11.97 | 1,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-03-19 | 1,900 | $21.76 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-03-16 | 15,416 | $0.00 | 15,416 | $11.97 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2018-03-19 | 1,900 | $0.00 | 1,900 | $11.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 198,584 | 2027-01-03 | No | 4 | M | Direct | |
| 196,684 | 2027-01-03 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.42, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.75 to $21.80, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- This stock option was issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. The option vests over four years, with 53,500 of the shares of common stock underlying the option vesting on 1/1/2018 and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service.
Billionaire Hedge Funds
